Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave
American Journal of Transplantation · 2023
DOI: 10.1111/ajt.17199 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Transplantation, 2023. Verfasst von Javier T Solera und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ajmera Transplant Centre, University Health Network, Toronto, Canada. Hauptthemen laut MEDLINE: COVID-19, Organ Transplantation. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ajmera Transplant Centre, University Health Network, Toronto, Canada.
- Ajmera Transplant Centre, University Health Network, Toronto, Canada. Electronic address: deepali.kumar@uhn.ca.
Zitieren
APA
Solera, J. T., Árbol, B. G., Bahinskaya, I., Marks, N., Humar, A., & Kumar, D. (2023). Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave. American Journal of Transplantation. https://doi.org/10.1111/ajt.17199
Vancouver
Solera JT, Árbol BG, Bahinskaya I, Marks N, Humar A, Kumar D. Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave. American Journal of Transplantation. 2023. doi:10.1111/ajt.17199
BibTeX
@article{Solera2023,
author = {Solera, Javier T and Árbol, Berta G and Bahinskaya, Ilona and Marks, Nikki and Humar, Atul and Kumar, Deepali},
title = {Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave},
journal = {American Journal of Transplantation},
year = {2023},
doi = {10.1111/ajt.17199}
}
EUVIMED